Pendulum Therapeutics
The Next Generation of Probiotics.
- Headquarters
- San Francisco Bay Area, California
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2C
- Website
- wholebiome.com
- Total Funding
- $120.9M
- Last Round
- $10.0M Corporate RoundJun 2023
About
Pendulum Therapeutics is a microbiome science company that develops next-generation probiotics targeting the gut microbiome to improve metabolic health. Its clinically validated products include strains like Akkermansia muciniphila and formulations shown to reduce blood sugar in Type 2 diabetes. Pendulum sells direct-to-consumer and through healthcare practitioners, recently expanding to GLP-1 and sports performance formulations.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account